About a third of patients who took the anti-acne drug Accutane developed elevated cholesterol levels, and over 40 percent showed raised levels of blood fats called triglycerides, a new report warns.
In people who have experienced a stroke, but who have no known history of coronary heart disease, beginning regular treatment with the cholesterol-lowering drug atorvastatin soon after the stroke can reduce the risk of recurrent stroke by 16 percent, according to a five-year study led by an international team that includes a researcher at Duke University Medical Center.
Nosodes is a term derived from the Greek word NOSO ? which signifies the prefix added to the word to form an idea of disease or indicating a relation to the disease.
A new study suggests that behavioral therapy plus medication is the most effective approach to treating trichotillomania, a psychiatric disorder characterized by obsessive hair pulling.
Deficits in certain neurological and psychological areas strongly predict conversion to Alzheimer’s disease (AD) in individuals with mild cognitive impairment, research shows.
In elderly patients with type 2 or non-insulin dependent diabetes, treatment with the short-acting drug repaglinide (NovoNorm) may be safer than that with the longer-acting drug, glibenclamide (glyburide), Italian researchers report.
Only one in five people with HIV in poor and middle-income countries receives the drugs that treat the virus, said a report by the U.S. Centers for Disease Control and Prevention on Thursday.
Elderly patients with heart disease who undergo coronary revascularization surgery enjoy better long-term health status and quality of life than those who are managed medically with drug therapy, according to results of a study.
For people with diabetes who also have abnormal levels of blood fats, or lipids, the combination of two types of cholesterol-lowering drugs seems to work better than either one alone, researchers report.
The Food and Drug Administration (FDA) today expanded the approved use of Oncaspar to include treating children and adults with newly diagnosed acute lymphoblastic leukemia (ALL) as part of a multiple drug chemotherapy regimen. FDA previously approved Oncaspar in 1994 only for patients with ALL who were unable to receive the cancer drug L-asparaginase because they were allergic to that drug.